We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Colorectal Surgery Device Prevents Need for Ostomy

By HospiMedica International staff writers
Posted on 05 Feb 2018
Image: The Colovac endoluminal bypass sheath protects against anastomotic leakage (Photo courtesy of SafeHeal).
Image: The Colovac endoluminal bypass sheath protects against anastomotic leakage (Photo courtesy of SafeHeal).
A new endoluminal bypass sheath could help surgeons avoid the need for a diverting ostomy in patients undergoing colectomy.
 
The SafeHeal (Paris, France) Colovac device is a seamless, minimally invasive, and fully reversible flexible bypass sheath that is intended to reduce any contact of fecal content with the colorectal anastomotic site, following open or laparoscopic colorectal surgery. It is anchored above the anastomosis using a stent combined with a vacuum-based mechanism; once in place, the implant covers the colon down to the anus, remaining in place until healing and tissue repair processes are complete, after which it is removed in an endoscopic procedure.
 
Colovac thus enables patients to resume their normal life without having to bear an artificial anus and wear ostomy pouches for several months. For the device’s European CE mark study, 15 colorectal surgery patients initially scheduled to receive a diverting ostomy will receive a Colovac device in lieu of the ostomy. The two first procedures were recently carried out at the Institute of Image-Guided Surgery (Strasbourg, France), in collaboration with CHU de Strasbourg (France).
 
“There is a high clinical and economic need for a disruptive product such as Colovac, which effectively reduces anastomotic leakage rates following colorectal surgery, while avoiding the distressing impacts of an ostomy for patients,” said Karl Blohm, CEO of SafeHeal. “This trial is a significant milestone in moving SafeHeal towards regulatory approval in Europe and the US.”
“In the two cases we performed, the Colovac procedure was very simple, safe and well received by the patients. We look forward to further participating in the clinical evaluation of this technology,” said digestive surgeon Antonio D’Urso, MD, principal investigator of the study. “Based on this early experience, the trial confirms the good usability of the device, its placement and retrieval, in line with preclinical experiments.”
 
Anastomotic leakage occurs in up to 20% of patients undergoing anterior resection. It is considered to be the most serious colorectal surgical complication, frequently resulting in the rapid development of severe peritonitis, septic shock, and multiple organ dysfunction. Ostomy, the current standard of care to reduce the risk of anastomotic leakage, is a traumatic and aggressive process that significantly reduces the quality of life of patients and entails its own complications.
 
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Measuring Rod
seca 233
New
Open Stapler
PROXIMATE Linear Cutter

Channels

Critical Care

view channel
Image: The skin-like sensor monitors internal and external body movement, and electrical signals (Photo courtesy of Huanyu “Larry” Cheng and Jennifer M. McCann)

Skin-Like Sensor Monitors Vital Signs and Tracks Healing After Surgery

Medical conditions such as bladder control issues and the need for monitoring vital signs after surgery require precise, long-term tracking to improve patient outcomes. These conditions can be challenging... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more